Scientific Advisory Board

LCRF’s Scientific Advisory Board includes renowned scientists, physicians and thought leaders spanning a broad range of disciplines in lung cancer research. Many of the members are also affiliated with leading cancer centers in the United States.

The Scientific Advisory Board leverages its collective experience and expertise to maintain the objectivity of LCRF’s grant selection process and help ensure that the Foundation continues to fund innovative, high-reward research that might otherwise go uninvestigated.

Scientific Advisory Board Members

James B. Dougherty, MD (Chair)

LCRF Board of Directors
General Partner, Arcus Ventures

Brendon Stiles, MD (Vice Chair)

LCRF Board of Directors
Associate Professor of Cardiothoracic Surgery
Weill Cornell Medical College

Jan Baranski, PhD (Ex Officio)

Director of Scientific Programs, LCRF

Julie Brahmer, MD

Interim Director, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Associate Professor of Oncology
Johns Hopkins Medical Center

David P. Carbone, MD, PhD

Professor of Medicine
Director, James Thoracic Center
Ohio State University

Steven M. Dubinett, MD

Professor and Chief, Division of Pulmonary and Critical Care Medicine
Director, UCLA Lung Cancer Research Program
Senior Associate Dean for Clinical and Translational Science
David Geffen School of Medicine at UCLA

Eric Haura, MD

Associate Professor in Oncology and Medicine
Program Leader, Experimental Therapeutics
Director, Lung Comprehensive Research Center
H. Lee Moffitt Cancer Center & Research Institute

Roy Herbst, MD, PhD

Professor of Medicine and Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Comprehensive Cancer Center | Yale School of Medicine | Smilow Cancer Hospital

John Heymach, MD, PhD

Associate Professor, Thoracic/Head and Neck Medical Oncology
Chief, Section of Thoracic Medical Oncology
The University of Texas MD Anderson Cancer Center

Mark Kris, MD

William and Joy Ruane Chair in Thoracic Oncology
Memorial Sloan Kettering Cancer Center

Donald W. Kufe, MD

Professor of Medicine
Leader, Translational Pharmacology and Early Therapeutic Trials Program
Dana-Farber/Harvard Cancer Center | Harvard Medical School

Marc Ladanyi, MD

Chief, Molecular Diagnostics Service
William J. Ruane Chair in Molecular Oncology
Memorial Sloan Kettering Cancer Center

Matthew Meyerson, MD, PhD

Professor, Department of Pathology
Professor of Pathology, Medical Oncology
Director, Center for Cancer Genome Discovery
Dana-Farber Cancer Institute | Harvard Medical School

Katerina Politi, PhD

Associate Professor of Pathology
Yale School of Medicine

Jack A. Roth, MD

Chief, Section of Thoracic Molecular Oncology
Professor, Department of Thoracic and Cardiovascular Surgery
The University of Texas MD Anderson Cancer Center

Charles M. Rudin, MD, PhD

Chief of Thoracic Oncology Service
Co-Director, Druckenmiller Center for Lung Cancer Research
Memorial Sloan Kettering Cancer Center

Ralph R. Weichselbaum, MD

Daniel K. Ludwig Distinguished Service Professor of Radiation and Cellular Oncology
Chair, Department of Radiation and Cellular Oncology
The University of Chicago Medical School

Kwok-Kin Wong, MD, PhD

Scientific Director, Belfer Institute for Applied Cancer Science
Professor of Medicine
Dana-Farber Cancer Institute | Harvard Medical School